For close to a decade, we’ve heard much about the promises of continuous manufacturing (CM) for oral solid dosage (OSD). So now that four OSD drugs are being manufactured by CM in the United States (at Vertex, Janssen, and Lilly), with at least five more in the approval pipeline, it’s time to take stock: Has CM delivered on its promises?
To read more go to https://ispe.org/pharmaceutical-engineering/november-december-2018/continuous-osd-field-status-update
